Risk of myocardial infarction with use of selected non-steroidal anti-inflammatory drugs in patients with spondyloarthritis and osteoarthritis.

Maureen DubreuilQiong Louie-GaoChristine E PeloquinHyon K ChoiYuqing ZhangTuhina Neogi

Published in: Annals of the rheumatic diseases (2018)

MI risk in SpA is increased among current users of diclofenac, but not naproxen. The MI risk with diclofenac in SpA appears to differ from that in OA.

Keyphrases

anti inflammatory drugs
knee osteoarthritis
rheumatoid arthritis
left ventricular
ankylosing spondylitis
disease activity
systemic lupus erythematosus
atrial fibrillation